共 50 条
- [1] Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (23): : 2169 - 2181
- [2] AN ATYPICAL CASE OF ATYPICAL HEMOLYTIC-UREMIC SYNDROME [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S546 - S547
- [3] Eculizumab in Atypical Hemolytic-Uremic Syndrome [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1377 - 1378
- [4] Atypical hemolytic-uremic syndrome related to abnormalities within the complement system [J]. REVUE DE MEDECINE INTERNE, 2011, 32 (04): : 232 - 240
- [5] Thrombomodulin Mutations in Atypical Hemolytic-Uremic Syndrome [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (04): : 345 - 357
- [7] Eculizumab in Atypical Hemolytic-Uremic Syndrome Reply [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1379 - 1380
- [8] Atypical Hemolytic-Uremic Syndrome: A Clinical Review [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (01) : E151 - E158
- [9] Eculizumab for Atypical Hemolytic-Uremic Syndrome. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05): : 542 - 544
- [10] Pharmacological treatment of atypical hemolytic-uremic syndrome [J]. EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (02): : 123 - 135